Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
AddLife buys Wellspect's surgery and respiration business
December 20, 2018

The life science group AddLife has signed an agreement with Wellspect HealthCare on the acquisition of its business in the product areas surgery and respiration. The business has sales of about EUR 17m, with eight markets in Europe and Australia accounting for more than 90 percent of sales. The purchase consideration for the business is EUR 18 million corresponding to an EV/sales of 1.1x.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: